Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:brand |
Estrostep Fe
|
| gptkbp:category |
Category X
|
| gptkbp:class |
combination oral contraceptive
|
| gptkbp:clinical_trial |
prevent pregnancy
manage menstrual disorders treat acne reduce risk of ovarian cysts studied for acne treatment studied for endometriosis studied for polycystic ovary syndrome |
| gptkbp:contraindication |
liver disease
certain cancers history of blood clots smoking over age 35 |
| gptkbp:dosage_form |
oral tablet
|
| gptkbp:effective_date |
gptkb:1999
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Estrostep
|
| gptkbp:ingredients |
gptkb:norgestimate
gptkb:ethinyl_estradiol |
| gptkbp:interacts_with |
gptkb:St._John's_Wort
antibiotics anticonvulsants HIV medications |
| gptkbp:is_used_for |
contraception
regulating menstrual cycle |
| gptkbp:lifespan |
approximately 24 hours
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:marketed_as |
gptkb:Australia
gptkb:United_Kingdom gptkb:United_States gptkb:Native_American_tribe |
| gptkbp:metabolism |
liver
|
| gptkbp:packaging |
blister pack
|
| gptkbp:pharmacokinetics |
absorbed in gastrointestinal tract
|
| gptkbp:population |
women of reproductive age
missed dose instructions take at the same time daily may not protect against ST Is not effective if missed multiple doses |
| gptkbp:previous_name |
norgestimate and ethinyl estradiol
|
| gptkbp:requires |
prescription only
|
| gptkbp:shelf_life |
2 to 3 years
|
| gptkbp:side_effect |
headache
nausea weight gain breast tenderness mood changes |
| gptkbp:storage |
room temperature
|
| gptkbp:bfsParent |
gptkb:ethinylestradiol
|
| gptkbp:bfsLayer |
6
|